MedTrace Logo

Evaluation of Hormonal Contraceptive Treatments in Obese Women

NCT02398903 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 174

Last updated 2018-08-13

No results posted yet for this study

Summary

The aim of our study is to assess the concentrations of different oral contraceptive agents in morbid obese women before and after two types of bariatric surgeries (RYGB and sleeve gastrectomy) in order to study the role of the surgery and the role of body weight on drug concentrations, and to compare these concentrations with those of normal-weight women.

Conditions

  • Obesity
  • Bariatric Surgery Candidate
  • Oral Contraceptive

Interventions

OTHER

Blood samples for measurement of drug Css

Blood samples for measurement of drug Css

OTHER

DXA and impedancemetry

Body composition by DXA and impedancemetry

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Anne Bachelot, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-16
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02398903 on ClinicalTrials.gov